Lucas Dow
Analyst · BMO Capital Markets
Welcome, and thank you for joining Elevra Lithium's September 2026 Quarterly Update. I'm joined today by Christian Cortes, Chief Financial Officer; Sylvain Collard, Chief Operating Officer and President of Canada; and Andrew Barber, Chief Development and Investor Relations Officer. As a reminder, any dollar amounts quoted today are in U.S. dollars and unit costs and revenues are reported on an FOB basis. The September quarter was a strong start to FY '27. At NAL, we delivered record ore mines, a record for mill throughput and the second highest concentrate production in the operation's history. We sold 58,134 tonnes of spodumene concentrate, 71% more than the last quarter, which led to a 137% increase in revenue to $74 million. Unit operating costs fell 14% to $780 per tonne sold, and we finished the quarter with $319 million in cash. Beyond the strong operational performance, the NAL expansion moved into execution. We signed 2 binding offtake agreements, and we further simplified the portfolio by selling our interest in Ewoyaa. Whilst we generally had a strong operational quarter, our safety performance was below our expectations. There were 6 recordable injuries in the September 2026 quarter compared to 4 total recordable injuries in the previous 2 quarters. This drove an increase in our total recordable injury frequency rate, which has resulted in an enhanced focus across the whole company to improve our safety performance. Across the organization, our team worked 20% more hours than last quarter, largely because of the growing activity around the NAL expansion, and that makes consistent safety standards even more important. In reviewing the incidents, we determined that the appropriate response is to reinforce the fundamentals, more coaching, more visible leadership in the field, consistent application of critical risk controls and renewed emphasis on the tools available to every person. I'd also like to acknowledge Sylvain and his leadership team at NAL for their commitment to getting this right. Turning now to production. In mining, we moved just over 466,000 tonnes of ore, 25% higher than the June quarter and a quarterly record as mining moved into areas posting thicker veins. This increase in ore mined and ore uncovered provided continued flexibility for the quarter's operations and allowed us to adequately prepare for potential impacts associated with weather during the North American winter season. In the mill, we processed just under 365,000 tonnes of ore, which was another quarterly record. The mill continues to operate with a sustained high level of performance and achieved a third consecutive quarter where utilization topped 90% despite a planned maintenance shutdown also being undertaken in the quarter. Maintaining a high level of mill utilization, good sorting performance on the ROM pad and crushing circuit and a modest increase in the mill feed grade helped hold recovery steady at 70% and translated into 54,907 tonnes of spodumene concentrate being produced at an average grade of 5.1%. On costs, unit operating costs were $780 per tonne sold, improved by 14% from $907 last quarter. Two key things drove that. First, volume. Production costs fell 2%, while we mined 25% more ore and held concentrate production, which gave us volume leverage across the operation. Second, ore processing costs fell 14% on better crusher performance, stronger plant reliability and operating efficiencies. A stronger U.S. dollar against the Canadian dollar also lowered our reported costs by about $9 per tonne sold. Capital expenditure at NAL was $9 million, covering planned sustaining capital projects and early work on the expansion, which we will cover in more detail shortly. On the commercial side, we sold 58,134 tonnes of spodumene concentrate, up 71% on the June quarter. The average realized price was $1,276 per tonne FOB, which is $1,524 per tonne on an SC6 equivalent basis. On a per tonne basis, our average realized pricing increased by 39% compared to the June quarter, and we generated $74 million in revenue. After concluding sales that lagged pricing in the previous quarter, we've moved to selling cargoes priced based on prevailing prices either at the time of sale or with the final price determined after the shipment arrives at its destination. As a result of this change, our sales in September quarter were priced on a provisional basis, as final pricing for the 2 shipments dispatched during the period will be determined during the December quarter. Accordingly, the reported price may alter once the sale is finalized. And while lithium prices have been volatile, the physical market for the spodumene concentrate remains tight. Based on the conversations we're having with customers, both current and prospective, the recent softness in pricing looks to be sentiment-driven and not a reflection of the physical market, where we continue to see strong demand for concentrate produced at NAL. This is also reflected in our progress against the commercial strategy we outlined with our FY '26 annual results, and we were pleased to announce 2 binding offtake agreements recently. In August, we finalized a supply agreement with Mangrove Lithium for the supply of up to 144,000 tonnes per year for Mangrove's proposed lithium chemical conversion facility in Canada. Then on October 8, we signed a binding agreement with LG Energy Solution to supply a base volume of 240,000 tonnes of spodumene concentrate over a 3-year period. Supply under that contract is expected to begin this calendar year, and we view LGES as a credible buyer for a meaningful portion of NAL's production volumes. We see these 2 agreements being consistent with the goal of improving our customer offtake terms to deliver greater commercial certainty and better financial outcomes for Elevra. Turning now to our strategic initiatives. In September, we published a pre-feasibility study for the staged NAL expansion. Through further engineering and evaluation of the opportunity, we see a pathway to increasing average annual concentrate production to 373,000 tonnes per year on a post-expansion basis. Compared to the previous scoping study released in May, this is a 10% uplift due to the impact of improved mill feed grades when incorporating the expected benefits of ore sorting. Life-of-mine average C1 operating costs are projected to fall to $630 per tonne as the benefit of increased production flows through the cost structure. The important item for this quarter is that the expansion project has moved into execution following the late June groundbreaking. Detailed engineering is underway. We have issued procurement packages for long lead items, and we mobilized teams at site to dismantle NAL's legacy carbonate plant to make room for the mechanical upgrades in the mill. The PFS confirmed that the upfront capital cost of expansion remains unchanged from prior estimates and the expansion remains on schedule, on budget and fully funded through the strategic financing package we announced in May. As part of the financing package, shareholders approved the issuance of the upfront tranche of the convertible notes to Canada Growth Fund at the July 16 Extraordinary General Meeting. And consequently, we issued $46 million of convertible notes in August. At Moblan, our focus is permitting, which remains the critical path. Fieldwork continued through the quarter to document baseline conditions to support permitting requirements. We've also commenced a scoping study, building on the 2024 definitive feasibility study to incorporate the project's expanded resource base and evaluate optimal plant sizing and staged development options. The scoping study is expected to be completed in the second quarter of FY '27. In the United States, we continue to advance permitting and community engagement for the Carolina Lithium Project. The North Carolina Division of Air Quality issued the draft air permit for public comment and a public hearing was held in October. We also hosted an open community meeting at our Cherryville office to give an update and take questions. We've also continued to focus our portfolio on North America. In October, we completed the sale of our interest in the Ewoyaa Project to Huayou Cobalt for approximately $71 million in cash before fees and taxes. The sale simplifies our structure, removes the complexity of Ewoyaa's joint venture and offtake agreements and eliminates future capital commitments to the project. In Western Australia, we completed the sale of our rights over the Tabba Tabba tenement to Wildcat Resources for a total consideration of AUD 16 million, whilst keeping a contingent royalty on any mineral resource Wildcat announces on the acquired tenement. We received AUD 5 million as an upfront payment, combined with AUD 8 million in Wildcat shares. We've since sold the Wildcat shares for a total of AUD 9 million. A deferred payment of AUD 3 million remains outstanding. We also announced a nonbinding term sheet to expand the Morella Joint Venture in which we hold 49%. Under the proposal, Morella can earn 51% of 4 exploration projects by funding AUD 300,000 of exploration within 2 years. These deliberate and considered steps reduce the cost of maintaining stand-alone exploration capability and let us focus capital and management time on our North American projects. We'll be holding our Annual General Meeting on the 19th of November. As we previously foreshadowed, we announced our planned Board transition, which will take effect at the close of the meeting. Allan Buckler and Jorge Beristain have voluntarily resigned as nonexecutive directors, which will reduce the Board size from 8 to 6. The Nomination and Remuneration Committee reviewed the Board's composition and confirmed that the Board remains well structured with the majority of independent directors, and we'd like to thank Allan and Jorge for their contributions over the years. Finally, our financial position. We ended the September quarter with $319 million in cash, up from $255 million at the end of June. That increase reflects the $46 million we received from the issue of the convertible notes together with $34 million in cash generated from operations at NAL as sales, volumes, and prices both rose. The proceeds from the Ewoyaa sale, approximately $71 million in cash before fees and taxes were received in October and, as such, are not included in the September cash balance. NAL capital expenditure for the quarter was $9 million, and we expect this quarterly spend to increase as we progress throughout the year as we ramp up spending on the NAL expansion and Moblan study development work. As we outlined in our full year 2026 results, we expect to incur between $120 million and $140 million in total capital expenditure in FY '27 with $100 million to $120 million allocated to the NAL expansion and Moblan studies. Between the cash on hand at the end of September, the proceeds from the sale of our Ewoyaa interest and the remaining capital available through the convertible notes with CGF, we continue to see our near-term growth projects being fully funded. To sum up, the September quarter was a strong operational and commercial start to FY '27, with safety the clear area for improvement. We remain confident in the outlook for lithium and in the path we have set for Elevra. And with that, we'll be happy to take questions.